Evidence map›Paper›PMID 35522355›Full record

ReviewCurrent diabetes reports2022

Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes.

Molly L Tanenbaum, Persis V Commissariat

Abstract readReview
In one paragraph

Review in Current diabetes reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Continuous glucose monitoring in type 2 diabetes: a systematic review of barriers and opportunities for care improvement.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2025
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. ChatCLIDS: Simulating Persuasive AI Dialogues to Promote Closed-Loop Insulin Adoption in Type 1 Diabetes Care.Proceedings of the ... AAAI Conference on Artificial Intelligence. AAAI Conference on Artificial Intelligence · 2026
    Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Narrative Review: Continuous Glucose Monitoring (CGM) in Older Adults with Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Molly L TanenbaumDepartment of Pediatrics, Division of Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, CA, USA. mollyt@stanford.edu.ORCID 0000-0003-4222-4224
Persis V CommissariatPediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Boston, MA, USA.ORCID 0000-0002-6964-1223

Funding

ONBOARD: OvercomiNg Barriers & Obstacles to Adopting Diabetes DevicesK23DK119470 · NIDDK · STANFORD UNIVERSITY · PI TANENBAUM, MOLLY LEAH · 2019 to 2023
$988k
NIDDK NIH HHS K23 DK119470NIDDK NIH HHS K23DK119470
6 · The paper itself

Abstract

purpose of reviewDiabetes technology (insulin pumps, continuous glucose monitoring, automated insulin delivery systems) has advanced significantly and provides benefits to the user. This article reviews the current barriers to diabetes device adoption and sustained use, and outlines the known and potential facilitators for increasing and sustaining device adoption. RECENT

findingsBarriers to diabetes device adoption continue to exist at the system-, provider-, and individual-level. Known facilitators to promote sustained adoption include consistent insurance coverage, support for providers and clinics, structured education and support for technology users, and device user access to support as needed (e.g., through online resources). Systemic barriers to diabetes device adoption persist while growing evidence demonstrates the increasing benefits of newest devices and systems. There are ongoing efforts to develop evidence-based structured education programs to support device adoption and sustained use.

Indexed as

Diabetes Mellitus, Type 1InsulinsBlood GlucoseBlood Glucose Self-MonitoringHumansInsulin Infusion SystemsBlood GlucoseInsulinsAutomated insulin delivery systemsBarriersContinuous glucose monitoringInsulin pumpsType 1 diabetes

Identifiers

PMID35522355
PMCPMC9189072

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.